MedPath
TGA Approval

TOLVAPTAN GH tolvaptan 30 mg + 90 mg tablet blister composite pack (417518)

417518

TOLVAPTAN GH tolvaptan 30 mg + 90 mg tablet blister composite pack

Lupin Australia Pty Limited

October 30, 2024

Medicine

Medicine

Active

Registered

Active Ingredients

tolvaptan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TOLVAPTAN GH tolvaptan 30 mg + 90 mg tablet blister composite pack (417518) - TGA 批准文号 | MedPath